Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to (68)Ga-DOTATATE/-TOC uptake

BACKGROUND: The prognosis of patients with progressive meningioma after failure of surgery and radiotherapy is poor. METHODS: We retrospectively evaluated the safety and efficacy of somatostatin-receptor (SSTR)-targeted radionuclide therapy ((177)Lu-DOTATATE [n = 16], (90)Y-DOTATOC [n = 3], or both...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Seystahl, Katharina, Stoecklein, Veit, Schüller, Ulrich, Rushing, Elisabeth, Nicolas, Guillaume, Schäfer, Niklaus, Ilhan, Harun, Pangalu, Athina, Weller, Michael, Tonn, Jörg-Christian, Sommerauer, Michael, Albert, Nathalie L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2016
Aiheet:
Clinical Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063513/
https://ncbi.nlm.nih.gov/pubmed/27106404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now060
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia